Also, during tumor progression, dynamic changes in EpCAM expression occur, prompting the use of enrichment systems that enable the simultaneous investigation of both EpCAM+ and EpCAM− CTCs to gain a more comprehensive understanding of EpCAM’s role in tumor progression [155]. Here, EPCAM is linked to neoplasm.